Selection of a peptide mimicking neutralization epitope of hepatitis E virus with phage peptide display technology

World Journal of Gastroenterology

Volumn 10, Issue 11, 2004, Pages 1583-1588

  Gu, Ying ^a   Zhang, Jun ^a   Wang, Ying Bing ^a   Li, Shao Wei ^a   Yang, Hai Jie ^a   Luo, Wen Xin ^a   Xia, Ning Shao ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BINDING PROTEIN; DIMER; EPITOPE; HEPATITIS B CORE ANTIGEN; HISTONE; ISOLEUCINE; LEUCINE; MONOCLONAL ANTIBODY; PEPTIDE; POLYMER; POLYPROTEIN; PROLINE; RECOMBINANT PROTEIN; SERINE; SUBUNIT VACCINE; THREONINE; TYROSINE;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BIOSENSOR; BIOTECHNOLOGY; CONTROLLED STUDY; DNA SEQUENCE; ESCHERICHIA COLI; FEASIBILITY STUDY; HEPATITIS E VIRUS; MOLECULAR MIMICRY; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; PHAGE DISPLAY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SCREENING TEST; TRANSMISSION ELECTRON MICROSCOPY; VIRUS NEUTRALIZATION; VIRUS PARTICLE; WESTERN BLOTTING;

EID: 2942726489     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i11.1583     Document Type: Article

References (31)

1. Zhuang H, Cao XY, Liu CB, Wang GM. Epidemiology of hepatitis E in China. Gastroenterol Jpn 1991; 26 (Suppl 3): 135-138
2. Huang RT, Li XY, Xia XB, Yuan XT, Liu MX, Li DR. Antibody detection and sequence analysis of sporadic HEV in Xiamen region. World J Gastroenterol 1999; 5: 270-272
3. Purcell RH, Emerson SU. Hepatitis E virus In Knipe DM, Howley PM, Griffin DE, eds. Fields virology, 4thed. vol2. Philadelphia: Lippincott Raven Pub 2001: 3051-3061
4. Li SW, Zhang J, He ZQ, Ge SX, Gu Y, Ling J, Liu RS, Xia NS. The study of aggregate of the ORF2 peptide of hepatitis E virus expressed in Escherichia coli. Shengwu Gongcheng Xuebao 2002; 18: 463-467
5. Ge SX, Zhang J, Huang GY, Pang SQ, Zhou KJ, Xia NS. The immuno-protect study of a hepatitis E virus ORF2 peptide expressed in E.coli. Weishengwu Xuebao 2003; 43: 35-42
6. Li SW, He ZQ, Wang YB, Chen YX, Liu RS, Lin J, Gu Y, Zhang J, Xia NS. Interface domain of hepatitis E virus capsid protein homodimer. Shengwu Gongcheng Xuebao 2004; 20:90-98
7. Gu Y, Zhang J, Li SW, Ge SX, He ZQ, Zhu ZH, Man YL, Li YM, Xia NS. Characterazation of the anti-HEV ORF2 monoclonal antibodies by biosensor. Xibao Yu Fenzi Mianyixue Zazhi 2002; 18: 617-620
8. Ge SX, Zhang J, Peng G, Huang GY, He ZQ, Gu Y, Zhu ZH, Ng MH, Xia NS. Development and evaluation of ELISAs for anti-hepatitis E virus IgM and IgG detection based on polmerized recombinant antigen. Bingdu Xuebao 2003; 19: 78-86
9. Gu Y, Ge SX, Huang GY, Li SW, Zhu ZH, He ZQ, Chen YX, Wang YB, Zhang J, Xia NS. Identification of neutralizing monoclonal antibodies to the hepatitis E virus. Bingdu Xuebao 2003; 19: 217-223
10. Bottcher B, Wynne SA, Crowther RA. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature 1997; 386: 88-91
11. Ding CL, Yao K, Zhang TT, Zhou F, Xu L, Xu JY. Generation of cytotoxic T cell against HBcAg using retrovirally transduced dendritic cells. World J Gastroenterol 2003; 9: 1512-1515
12. Luo WX, Zhang J, Yang HJ, Li SW, Xie XY, Pang SQ, Li SQ, Xia NS. Construction and application of an Escherichia coli high effective expression vector with an enhancer. Shengwu Gongcheng Xuebao 2000; 16: 578-581
13. 7 mAb by phage display technology. World J Gastroenterol 2001; 7: 510-514
14. Wu BP, Xiao B, Wan TM, Zhang YL, Zhang ZS, Zhou DY, Lai ZS, Gao CF. Construction and selection of the natural immune Fab antibody phage display library from patients with colorectal cancer. World J Gastroenterol 2001; 7: 811-815
15. Ferrer M, Sullivan BJ, Godbout KL, Burke E, Stump HS, Godoy J, Golden A, Profy AT, van Schravendijk MR. Structural and functional characterization of an epitope in the conserved C-terminal region of HIV-1 gp120. J Pept Res 1999; 54: 32-42
16. MacDonald NJ, Shivers WY, Narum DL, Plum SM, Wingard JN, Fuhrmann SR, Liang H, Holland-Linn J, Chen DH, Sim BK. Endostatin binds tropomyosin. A potential modulator of the antitumor activity of endostatin. J Biol Chem 2001; 276: 25190-25196
17. Kiczak L, Kasztura M, Koscielska-kasprzak K, Dadlez M, Otlewski J. Selection of potent chymotrypsin and elastase inhibitors from M13 phage library of basic pancreatic trypsin inhibitor (BPTI). Biochim Biophys Acta 2001; 1550: 153-163
18. Aramburu J, Yaffe MB, Lopez-Rodriguez C, Cantley LC, Hogan PG, Rao A. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 1999; 285: 2129-2133
19. Shchelkunov SN, Nesterov AE, Ryazankin IA, Ignat'ev GM, Sandakhchiev LS. Development of a candidate polyvalent live vaccine against human immunodeficiency, hepatitis B, and orthopox viruses. Dokl Biochem Biophys 2003; 390: 180-183
20. Ragupathi G, Livingston P. The case for polyvalent cancer vaccines that induce antibodies. Expert Rev Vaccines 2002; 1: 193-206
21. Cardo-Vila M, Arap W, Pasqualini R. Alpha v beta 5 integrin-dependent programmed cell death triggered by a peptide mimic of annexin V. Mol Cell 2003; 11: 1151-1162
22. Xu L, Jin BQ, Fan DM. Selection and identification of mimic epitopes for gastric cancer-associated antigen MG7 Ag. Mol Cancer Ther 2003; 2: 301-306
23. Grothaus MC, Srivastava N, Smithson SL, Kieber-Emmons T, Williams DB, Carlone GM, Westerink MA. Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library. Vaccine 2000; 18: 1253-1263
24. Prinz DM, Smithson SL, Westerink MA. Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C. J Immunol Methods 2004; 285: 1-14
25. Zhang JZ, Ng MH, Xia NS, Lau SH, Che XY, Chau TN, Lai ST, Im SW. Comformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatits E virus structural protein. J Med Virol 2001; 64: 125-132
26. Im SW, Zhang JZ, Zhuang H, Che XY, Zhu WF, Xu GM, Li K, Xia NS, Ng MH. A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus. Vaccine 2001; 19: 3726-3732
27. Pumpens P, Razanskas R, Pushko P, Renhof R, Gusars I, Skrastina D, Ose V, Borisova G, Sominskaya I, Petrovskis I, Jansons J, Sasnauskas K. Evaluation of HBs, HBc, and frCP virus-like particles for expression of human papillomavirus 16 E7 oncoprotein epitopes. Intervirology 2002; 45: 24-32
28. Sompuram SR, Kodela V, Ramanathan H, Wescott C, Radcliffe G, Bogen SA. Synthetic peptides identified from phage-displayed combinatorial libraries as immunodiagnostic assay surrogate quality-control targets. Clin Chem 2002; 48: 410-420
29. Poloni F, Puddu P, Moretti F, Flego M, Romagnoli G, Tombesi M, Capone I, Chersi A, Felici F, Cianfriglia M. Identification of a LFA-1 region involved in the HIV-1-induced syncytia formation through phage-display technology. Eur J Immunol 2001; 31: 57-63
30. Li BW, Rush A, Zhang SR, Curtis KC, Weil GJ. Antibody responses to Brugia malayi antigens induced by DNA vaccination. Filaria J 2004; 3: 1
31. Combredet C, Labrousse V, Mollet L, Lorin C, Delebecque F, Hurtrel B, McClure H, Feinberg MB, Brahic M, Tangy F. A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice. J Virol 2003; 77: 11546-11554